Search research articles
Contact Us
Filters
Showing results (1-10 of 75) with videos related to
Page
of 8
Sort By:
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|
October 21, 2017
What's new in the treatment of eczemas
Massimo Gola, Antonio Carpentieri, Francesco Loconsole
Dermatology Reports
|
February 6, 2026
Upadacitinib for the management of refractory hidradenitis suppurativa, psoriasis, and pyoderma gangrenosum
Giorgia Sbarra, Edoardo Mortato, Francesco Loconsole
Global & Regional Health Technology Assessment
|
January 11, 2023
Paolo Gisondi, Francesco Loconsole, Paola Raimondo, et al.
International Journal of Dermatology
|
November 28, 2002
Oral terbinafine for the treatment of seborrheic dermatitis in adults
Nicoletta Cassano, Antonella Amoruso, Francesco Loconsole, et al.
Dermatologic Therapy
|
April 27, 2010
Therapeutic hotline: Re-induction may be useful to manage psoriasis relapse during long-term maintenance treatment with infliximab: a retrospective analysis
Gino Vena, Francesco Loconsole, Valentina Mastrandrea, et al.
European Journal of Dermatology : EJD
|
March 20, 2015
Late paradoxical development of pyoderma gangrenosum in a psoriasis patient treated with infliximab
Michelangelo Vestita, Stefania Guida, Stella Mazzoccoli, et al.
European Journal of Dermatology : EJD
|
May 20, 2006
Psoriasis exacerbation after a flu-like syndrome during anti-TNF-alpha therapy
Nicoletta Cassano, Carmela Coviello, Francesco Loconsole, et al.
Dermatology Reports
|
April 16, 2024
Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies
Edoardo Mortato, Silvia Baratta, Luca Rubino, et al.
Italian Journal of Dermatology and Venereology
|
April 23, 2024
Risankizumab for severe psoriasis: a case of successful retreatment without induction after 15 months of discontinuation
Edoardo Mortato, Silvia Baratta, Riccardo Viola, et al.
Clinical Drug Investigation
|
December 14, 2006
Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol
Nicoletta Cassano, Antonio Miracapillo, Carmela Coviello, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 75) with videos related to
Sort By:
Page
of 8
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|
October 21, 2017
What's new in the treatment of eczemas
Massimo Gola, Antonio Carpentieri, Francesco Loconsole
Dermatology Reports
|
February 6, 2026
Upadacitinib for the management of refractory hidradenitis suppurativa, psoriasis, and pyoderma gangrenosum
Giorgia Sbarra, Edoardo Mortato, Francesco Loconsole
Global & Regional Health Technology Assessment
|
January 11, 2023
Paolo Gisondi, Francesco Loconsole, Paola Raimondo, et al.
International Journal of Dermatology
|
November 28, 2002
Oral terbinafine for the treatment of seborrheic dermatitis in adults
Nicoletta Cassano, Antonella Amoruso, Francesco Loconsole, et al.
Dermatologic Therapy
|
April 27, 2010
Therapeutic hotline: Re-induction may be useful to manage psoriasis relapse during long-term maintenance treatment with infliximab: a retrospective analysis
Gino Vena, Francesco Loconsole, Valentina Mastrandrea, et al.
European Journal of Dermatology : EJD
|
March 20, 2015
Late paradoxical development of pyoderma gangrenosum in a psoriasis patient treated with infliximab
Michelangelo Vestita, Stefania Guida, Stella Mazzoccoli, et al.
European Journal of Dermatology : EJD
|
May 20, 2006
Psoriasis exacerbation after a flu-like syndrome during anti-TNF-alpha therapy
Nicoletta Cassano, Carmela Coviello, Francesco Loconsole, et al.
Dermatology Reports
|
April 16, 2024
Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies
Edoardo Mortato, Silvia Baratta, Luca Rubino, et al.
Italian Journal of Dermatology and Venereology
|
April 23, 2024
Risankizumab for severe psoriasis: a case of successful retreatment without induction after 15 months of discontinuation
Edoardo Mortato, Silvia Baratta, Riccardo Viola, et al.
Clinical Drug Investigation
|
December 14, 2006
Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol
Nicoletta Cassano, Antonio Miracapillo, Carmela Coviello, et al.
Page
of 8